Ngā hua rapu - Rob Pieters

Whakamahine hua
  1. 1
    How I treat infant leukemia

    How I treat infant leukemia mā Patrick A. Brown, Rob Pieters, Andrea Biondi

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL

    Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL mā Rob Pieters, Charles G. Mullighan, Stephen P. Hunger

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Myocyte enhancer factor 2C in hematopoiesis and leukemia

    Myocyte enhancer factor 2C in hematopoiesis and leukemia mā Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia

    Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia mā Rob Pieters, D. R. Huismans, A. Leyva, A. Veerman

    I whakaputaina 1989
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine

    Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine mā Annelies Hartman, Cor van den Bos, Theo Stijnen, Rob Pieters

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment

    B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment mā Roel Polak, Bob de Rooij, Rob Pieters, Monique L. den Boer

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia

    Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia mā Pieter Van Vlierberghe, Rob Pieters, H. Berna Beverloo, Jules P.P. Meijerink

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia

    The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia mā Rui D. Mendes, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Allergic‐like reactions to asparaginase: Atypical allergies without asparaginase inactivation

    Allergic‐like reactions to asparaginase: Atypical allergies without asparaginase inactivation mā Robin Q.H. Kloos, Rob Pieters, Gabriele Escherich, Inge M. van der Sluis

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche

    Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche mā Bob de Rooij, Roel Polak, Femke Stalpers, Rob Pieters, Monique L. den Boer

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia

    Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia mā Trudy Buitenkamp, Ron A. A. Mathôt, Valérie de Haas, Rob Pieters, C. Michel Zwaan

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective

    Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective mā Judith M. de Bont, Roger J. Packer, Erna Michiels, Monique L. den Boer, Rob Pieters

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study

    Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study mā Gertjan J.L. Kaspers, LA Smets, Rob Pieters, CH Van Zantwijk, ER van Wering, A. Veerman

    I whakaputaina 1995
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia

    Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia mā Amy de Haar-Holleman, Monique L. den Boer, Karin M. Kazemier, Gritta Janka‐Schaub, Rob Pieters

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions

    In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions mā Rob Pieters, AH Loonen, DR Huismans, GJ Broekema, MW Dirven, MW Heyenbrok, K. Hählen, A. Veerman

    I whakaputaina 1990
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia

    Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia mā Ronald W. Stam, Pauline Schneider, Paola De Lorenzo, Maria Grazia Valsecchi, Monique L. den Boer, Rob Pieters

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    MEK inhibition is a promising therapeutic strategy for <i>MLL</i>-rearranged infant acute lymphoblastic leukemia patients carrying <i>RAS</i> mutations

    MEK inhibition is a promising therapeutic strategy for <i>MLL</i>-rearranged infant acute lymphoblastic leukemia patients carrying <i>RAS</i> mutations mā Mark Kerstjens, Emma M. C. Driessen, Merel Willekes, Sandra S. Pinhanços, Pauline Schneider, Rob Pieters, Ronald W. Stam

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies

    T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies mā Valentina Cordo’, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    MLL fusion-driven activation of<i>CDK6</i>potentiates proliferation in<i>MLL-</i>rearranged infant ALL

    MLL fusion-driven activation of<i>CDK6</i>potentiates proliferation in<i>MLL-</i>rearranged infant ALL mā Marieke van der Linden, Merel Willekes, Eddy van Roon, Lidija Seslija, Pauline Schneider, Rob Pieters, Ronald W. Stam

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Up-regulation of asparagine synthetase expression is not linked to the clinical response l-asparaginase in pediatric acute lymphoblastic leukemia

    Up-regulation of asparagine synthetase expression is not linked to the clinical response l-asparaginase in pediatric acute lymphoblastic leukemia mā Inge M. Appel, Monique L. den Boer, Jules P.P. Meijerink, A. Veerman, Nathalie C. M. Reniers, Rob Pieters

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: